The US Food and Drug Administration (FDA) recently issued its draft guidance, Considerations for the Use of Artificial Intelligence to ...

In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, highlights increased data management, DE&I, and ...

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), a leading biotechnology company specializing in cystic fibrosis (CF) treatments, has been making significant strides in expanding its therapeutic portfolio ...

ResMed’s stock has surged but faces potential risks from GLP-1 drugs. Find out why RMD stock remains a Hold as investors ...

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

Meta CEO Mark Zuckerberg said his company is planning to invest $60 billion to $65 billion in capital expenditures this year while growing the size of the company’s AI teams “significantly.” Last ...

New directive scraps Biden-era restrictions and accelerates AI innovation to bolster national security and economic growth.

Intuitive Surgical reported fourth-quarter earnings that topped analysts’ expectations as it boosted sales of its surgical ...

The landscape of AI regulation in the United States is undergoing significant changes, with President Donald Trump announcing ...

As the bird flu virus continues to spread through the United States, the Trump administration on Tuesday ordered all ...

President Trump’s executive order on January 23rd follows his repeal of Biden’s AI executive order, directing reviews of ...

President Donald Trump's administration has placed a freeze on information being released from government health agencies.